tiprankstipranks
Advertisement

CDC ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Strong Buy
16Bullish
4Neutral
2Bearish
Oscillators
Buy
4Bullish
4Neutral
2Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) Moving Averages Convergence Divergence (MACD) indicator is 0.21, suggesting VictoryShares US EQ Income Enhanced Volatility Wtd ETF is a Sell.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) 20-Day exponential moving average is 72.43, making it a Buy.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) 50-Day exponential moving average is 71.92, making it a Buy.

VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) Pivot Points

Jun 10, 2026, 03:21 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
71.90
72.30
72.37
72.77
72.84
73.24
73.31
Fibonacci
72.30
72.48
72.59
72.77
72.95
73.06
73.24

VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) Moving Averages

Jun 10, 2026, 03:21 PM
Period
Simple
Exponential
MA5
72.58Buy
72.70Buy
MA10
72.52Buy
72.58Buy
MA20
72.37Buy
72.43Buy
MA50
71.97Buy
71.92Buy
MA100
71.24Buy
70.75Buy
MA200
67.97Buy
68.15Buy
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) 10-Day exponential moving average is 72.58, making it a Buy.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) 100-Day exponential moving average is 70.75, making it a Buy.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) 50-day simple moving average is 71.97, creating a Buy signal.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) 100-day simple moving average is 71.24, creating a Buy signal.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) 200-day simple moving average is 67.97, creating a Buy signal.

VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) Technical Analysis

Jun 10, 2026, 03:21 PM
Name
Value
Action
RSI (14)
56.93
Neutral
STOCH (9,6)
49.25
Neutral
STOCHRSI (14)
46.37
Neutral
MACD (12,26)
0.21
Sell
ADX (14)
10.82
Buy
Williams %R
-41.31
Buy
CCI (14)
59.03
Neutral
ATR (14)
0.68
-
Ultimate Oscillator
25.58
Sell
ROC
1.27
Buy
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) Relative Strength Index (RSI) is 56.93, creating a Neutral signal.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) Trend Strength Indicator (ADX) is 10.82, creating a Buy signal.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) Commodity Channel Index (CCI) is 59.03, creating a Neutral signal.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) Price Rate of Change (ROC) is 1.27, creating a Buy signal.

FAQ

Is CDC a Buy, Hold, or Sell?
Based on CDC’s technical indicators, CDC is a Strong Buy.
    What is CDC’s RSI (14)?
    CDC’s RSI (14) is 56.93, which suggests CDC is a Neutral.
      What is CDC’s MACD?
      CDC’s MACD is 0.21, which suggests CDC is a Sell.
        What is CDC’s 5-day moving average?
        CDC’s 5-day moving average is 72.58, which suggests CDC is a Buy.
          What is CDC’s 20-day moving average?
          CDC 20-day moving average is 72.37, which suggests CDC is a Buy.
            What is CDC’s 50-day moving average?
            CDC’s 50-day moving average is 71.97, which suggests CDC is a Buy.
              What is CDC’s 200-day moving average?
              CDC’s 200-day moving average is 67.97, which suggests CDC is a Buy.
                What is CDC’s Williams % R (14)?
                CDC’s Williams % R (14) is -41.31, which suggests CDC is a Buy.
                  What is CDC’s CCI (14)?
                  CDC’s CCI (14) is 59.03, which suggests CDC is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement